Richard Douglas

(Dr. Richard Douglas Ph.D.)

Currently holds positions in Aldeyra Therapeutics Inc and Novavax Inc

Positions

Position Company Period
Independent Chairman of the Board Aldeyra Therapeutics Inc Sept. 1, 2016 -
Independent Director Novavax Inc Aug. 6, 2010 -
Richard Douglas's trades of MaxCyte Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-30 2023-03-29
US MaxCyte Inc (MXCT)
B Purchase
80,000 +400.0%
4.32
USD 345,480 		80,000 +400.0% 4.32 USD 345,480
2021-11-23 2021-11-22
US MaxCyte Inc (MXCT)
B Purchase
20,000 +inf%
11.12
USD 222,400 		20,000 +inf% 11.12 USD 222,400
2020-03-17 2020-03-16
B Purchase
40,000 +47.1%
2.75
USD 110,000 		40,000 +47.1% 2.75 USD 110,000
2019-09-17 2019-09-13
B Purchase
5,000 +6.2%
6.00
USD 30,000 		5,000 +6.2% 6.00 USD 30,000
2019-09-13 2019-09-12
B Purchase
10,000 +14.3%
6.03
USD 60,276 		10,000 +14.3% 6.03 USD 60,276
2019-09-13 2019-09-11
B Purchase
10,000 +16.7%
5.75
USD 57,529 		10,000 +16.7% 5.75 USD 57,529
2019-09-11 2019-09-10
B Purchase
10,000 +20.0%
5.09
USD 50,857 		10,000 +20.0% 5.09 USD 50,857
2019-09-11 2019-09-09
B Purchase
10,000 +25.0%
4.91
USD 49,106 		10,000 +25.0% 4.91 USD 49,106
// ... existing code ... // ... rest of the file ...